$525 Million is the total value of SECTOR GAMMA AS's 29 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 36.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| GILD | Buy | GILEAD SCIENCES INC | $48,830,000 | +62.0% | 838,140 | +75.7% | 9.29% | +35.4% |
| MRK | Buy | MERCK & CO INC | $47,298,000 | +45.0% | 578,211 | +47.0% | 9.00% | +21.2% |
| INCY | Buy | INCYTE CORP | $30,585,000 | +19.6% | 351,629 | +23.4% | 5.82% | +0.0% |
| BDX | New | BECTON DICKINSON & CO | $30,488,000 | – | 121,845 | +100.0% | 5.80% | – |
| BSX | Buy | BOSTON SCIENTIFIC CORP | $24,816,000 | +17.0% | 690,282 | +24.4% | 4.72% | -2.2% |
| PFE | New | PFIZER INC | $21,838,000 | – | 593,250 | +100.0% | 4.16% | – |
| IONS | Buy | IONIS PHARMACEUTICALS INC | $18,149,000 | +61.8% | 320,992 | +35.8% | 3.45% | +35.3% |
| CAH | Buy | CARDINAL HEALTH INC | $15,578,000 | +16.3% | 290,850 | +2.0% | 2.96% | -2.8% |
| LH | Buy | LABORATORY CORP AMER HLDGS | $14,669,000 | +29.3% | 72,064 | +19.6% | 2.79% | +8.1% |
| LIVN | Buy | LIVANOVA PLC | $13,323,000 | +105.6% | 201,230 | +40.4% | 2.54% | +71.9% |
| CNC | New | CENTENE CORP DEL | $11,647,000 | – | 194,012 | +100.0% | 2.22% | – |
| ELAN | Buy | ELANCO ANIMAL HEALTH INC | $11,295,000 | +102.1% | 368,291 | +84.0% | 2.15% | +68.9% |
| RIGL | Buy | RIGEL PHARMACEUTICALS INC | $5,595,000 | +70.7% | 1,598,649 | +17.1% | 1.06% | +42.8% |
| ALNY | Buy | ALNYLAM PHARMACEUTICALS INC | $3,849,000 | +35.6% | 29,615 | +51.9% | 0.73% | +13.3% |
| NVAX | New | NOVAVAX INC | $1,282,000 | – | 11,500 | +100.0% | 0.24% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-02-10
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BOSTON SCIENTIFIC CORP | 40 | Q1 2023 | 9.9% |
| BIO RAD LABS INC | 40 | Q1 2023 | 4.7% |
| BRISTOL-MYERS SQUIBB CO | 38 | Q3 2023 | 11.9% |
| BAXTER INTL INC | 34 | Q3 2023 | 12.7% |
| CARDINAL HEALTH INC | 34 | Q3 2023 | 8.1% |
| PERKINELMER INC | 33 | Q2 2021 | 6.3% |
| BIOGEN INC | 30 | Q3 2023 | 7.6% |
| ELEVANCE HEALTH INC | 30 | Q3 2023 | 5.6% |
| GILEAD SCIENCES INC | 29 | Q3 2023 | 14.0% |
| TENET HEALTHCARE CORP | 28 | Q3 2023 | 4.3% |
View SECTOR GAMMA AS's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-08 |
| 13F-HR | 2024-02-05 |
| 13F-HR | 2023-11-06 |
| 13F-HR | 2023-08-09 |
| 13F-HR | 2023-05-12 |
| 13F-HR/A | 2023-02-08 |
| 13F-HR | 2023-02-07 |
| 13F-HR | 2022-11-09 |
| 13F-HR | 2022-08-05 |
| 13F-HR | 2022-05-06 |
View SECTOR GAMMA AS's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.